Capital World Investors »

Halozyme Therapeutics Inc Note 1.000 8/1 shares owned by Capital World Investors

Quarter-by-quarter ownership of Halozyme Therapeutics Inc Note 1.000 8/1 shares owned by Capital World Investors from 13F filings

Historical chart of Capital World Investors investment in Halozyme Therapeutics Inc Note 1.000 8/1

Tip: Access up to 7 years of quarterly data

All positions including Halozyme Therapeutics Inc Note 1.000 8/1 held by Capital World Investors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Halozyme Therapeutics Inc Note 1.000 8/1 by Capital World Investors

Quarter filed Position value Share count Share price at filing
2025-09-30 $3.0M 2.2M 1.41

More positions owned by Capital World Investors

Broadcom (AVGO)
Microsoft Corporation (MSFT)
Meta Platforms Cl A (META)
NVIDIA Corporation (NVDA)
Philip Morris International (PM)
Tesla Motors (TSLA)
Alphabet Cap Stk Cl A (GOOGL)
Eli Lilly & Co. (LLY)
Netflix (NFLX)
Micron Technology (MU)
Vertex Pharmaceuticals Incorporated (VRTX)
Amazon (AMZN)
Cloudflare Cl A Com (NET)
Visa Com Cl A (V)
Shopify Cl A Sub Vtg Shs (SHOP)

View all positions for Capital World Investors

Top funds holding Halozyme Therapeutics Inc Note 1.000 8/1

Millennium Management
LMR Partners
Calamos Advisors
Camden Asset Management
Balyasny Asset Management
DLD Asset Management
Point72 Asset Management
Davidson Kempner Capital Management
Jpmorgan Chase & Co
Jain Global
Nuveen
Lazard Asset Management
State Street Corporation
Absolute Investment Advisers
Citadel Advisors

View all funds holding Halozyme Therapeutics Inc Note 1.000 8/1